With globalization bringing countries closer, medical tourism continues to bloom by offering high-quality healthcare provisions outside the domestic healthcare facilities. Medical Tourism aka health tourism offers patients with options to choose the best and budget-friendly healthcare treatment. Millions of medical tourists visit other countries in pursuit of affordable healthcare treatments.
Developing countries remain favorite…
Previously in PharmaShots Magazine, we explored Companion Animals as a theme. For the September Edition, our theme is centered on livestock animals. Livestock farming remains one of the key sectors in agrarian economies like India, China, and Latin American countries. Livestock farming provides us with milk and meat enriched with essential nutritional compounds like protein. …
Introducing the third installment of our recently launched Complimentary Exclusive Video Interview. Jonathan Usuka, Chief Business Officer at Sapient, highlighted Sapient’s high throughput proteomics and metabolomics capabilities to generate multi-omics data and the analytical power to transcend the genome to achieve robust biological discoveries in expediting clinical studies.
By leveraging Sapient's real-world data asset, the…
In August and September, PharmaShots is all set to explore Animal Health. A topic as diverse as Animal health requires at least two months to navigate the nuanced aspects of the industry. So, we decided to split the animal health segment into two: for August, we are exploring Companion Animals, and for the subsequent month,…
In the second reprise of our Complimentary Exclusive Video Interview, we had the pleasure to speak with Nick Kadysh, the Founding CEO and President of PharmAla Biotech. Our complimentary exclusive video interview is an initiative to voice the global biopharma leaders by offering them a platform to shed light on the developments in the healthcare…
In June, PharmaShots was busy covering the heavy influx of life science updates. Our most-read Top 20 reports covered Nutraceutical and Innovative Digital Therapeutics companies. For the Disease of the Month report, we covered Fabry Disease. The Know Your Investor report featured a condensed report on Google Ventures.
Like every Month, we published reports on Biosimilars, Designations, FDAand EMA approvals.
In August, PharmaShots will…
With great zeal, PharmaShots began an Exclusive Video Interview series for C-suites. An innovative idea to bring thought leaders of the industry, our Exclusive Video Interview offering is a noble initiative by PharmaShots to capture the developments of leading companies. As a part of offering, PharmaShots will be publishing exclusive video interviews every second Monday…
May had been a busy month for PharmaShots with an unceasing influx of life science updates.
In our most-read Top 20 section, we published reports on Diagnostic Companies and Medical Device Companies.
Like every month, PharmaShots published reports on Key Biosimilars Events, FDA approvals, and EMA approvals along with the New Drug Designation Report. In the Disease of the Month report, we explored Sjögren’s…
Throughout April PharmaShots was swamped with the heavy traffic of life science updates. As an official media partner to Reuters Events, PharmaShots was present in Barcelona, covering groundbreaking presentations from leading biopharma companies.
Our most-read top 20 section featured reports on Top 20 RNAi Therapeutic Companies, Top 20 Biopharma Deal Terminations of 2023, and Top 20 Biopharma Companies. For…
Following the Reuters Events Pharma USA 2024, PharmaShots brings an engaging conversation with Moreno Perugini, President, of Néstle Health Science. Moreno begins the conversation by highlighting Néstle’s journey to become a full-fledged pharma company through a series of acquisitions and deals.
Moreno recalls Néstle’s transitioning into a pharmaceutical company when the company got the rights for Zenpep,…

